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Partial V(D)J Recombination Activity
Leads to Omenn Syndrome
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activities Ku70, Ku80, and DNA-PK, are all essential forophilia, and high IgE levels, bear missense mutations
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Table 1. Analysis of OS Patients for Mutations in Rag-1 or Rag-2
Amino Acid
Patient Gene Nucleotide Change Domain
OS1 Rag-2 C1324G C41W HimA homology
T2055G M285R topoII homology
OS2 Rag-1 G1794A R561H Rag-2 interaction
OS3 Rag-1 C1298T R396C Homeodomain, DNA binding
A2847G Y912C Active core
OS4 Rag-1 G1299A R396H Homeodomain, DNA binding
deletion 1723±1735 Truncated protein
OS5 Rag-1 deletion 368±369 No protein
A1398G D429G Homeodomain,
Homodimerization
OS6 Rag-1 C1298T R396C Homeodomain, DNA binding
OS7 Rag-1 C1793T R561C Rag-2 interaction
G2322A R737H Active core
Omenn syndrome (OS) is a rare autosomal recessive mutations in either theRag-1 orRag-2 genes.The results
obtained at the nucleotide level are summarized in Tablegenetic disorder characterized by symptoms of severe
combined immunodeficiency associated with erythro- 1. Six of the patients (OS2±OS7) were found to have
an abnormality in the Rag-1 gene. Two patients weredermia, eosinophilia, hepatosplenomegaly, lymphade-
nopathy, and elevated serum IgE levels (Omenn, 1965; homozygous for a missense mutation, one (OS2) for a
G1794A mutation causing an R561H change, the otherOMIM 267700). Unless treated by bone marrow trans-
plantation, this disease is invariably fatal (Gomez et al., (OS6) for a C1298T transition leading to an R396C substi-
tution. The four remaining patients were compound het-1995). At variance with other forms of SCID, OS patients
have a variable number of circulating T cells that coex- erozygotes bearing missense mutations or deletions.
Patient OS5 had a 2 nt deletion (nt 368±369) in the firstpress activation markers and respond poorly to mitogens
and antigens. Previous studies have shown restricted allele leading to frameshift and premature translational
termination and an A1398G transition causing a D429Gheterogeneity of T cell receptor (TCR) rearrangements
in patients with OS (de Saint-Basile et al., 1991; Harville substitution in the second allele. Patient OS4 had a dele-
tion of 13 nucleotides (nt 1723±1735) in the first alleleet al., 1997). It has been suggested that the clinical and
immunological features of OS could be related to an resulting in frameshift and premature termination and a
G1299A transition affecting the same codon of patientunbalanced expansion of the T helper 2 (Th2) cell subset
as substantiated by increased production of interleukins OS6, but leading to a different amino acid substitution
(R396H). Patient OS3 had two missense mutations, the4 (IL-4) and 5 (IL-5), reduced synthesis of IL-2 and
g-interferon by in vitro activated lymphocytes (Schan- first (R396C) is identical to the one found in patient OS6,
while the second (A2847G) is found near the C terminusdeneÂ et al., 1993; Chilosi et al., 1996), and increased
numbers of CD30-expressing cells, a surface marker of Rag-1 (Y912C). Finally, patient OS7 also had two mis-
sense mutations, the firstaffecting a different nucleotidepreferentially expressed on Th2 cells (Chilosi et al.,
1996). The underlying molecular defect remained un- (C1793T) in the same codon as patient OS2 and causing
an R561C change, the second a G2322A transition,known although similarities with the murine scid model
have been described (Cavazzana-Calvo et al., 1993). which causes an R738H substitution.
Residues R396 and D429 are within the homeodomainWe report here the analysis of seven OS patients, all
of whom were found to bear recessive mutations in region of Rag-1 (Figure 1A) (Spanopoulou et al., 1996).
R396 represents the fifth residue of the pentapeptideeither the Rag-1 or Rag-2 genes. All OS mutations lead
to reduced V(D)J recombination activity and account for that shows absolute identity between the Hin and Rag-1
DNA-binding domains and has been proposed to medi-the immunodeficiency observed in OS patients. These
findings establish V(D)J recombination deficiencies as ate binding of the protein to the nonamer motif of the
RSS (Difilippantonio et al., 1996; Spanopoulou et al.,the molecular basis of OS.
1996). D429 is located at the beginning of helix III of the
Rag-1 homeodomain (Spanopoulou et al., 1996), whileResults
R561 is within the region of Rag-1 that mediates interac-
tion with Rag-2 (McMahan et al., 1997) (Figure 1A). AllDetection of Rag Mutations in OS Patients
We studied seven patients fulfilling the criteria for Omenn three amino acids of Rag-1, R396, D429, and R561 have
been conserved throughout evolution (Sadofsky et al.,syndrome, i.e., early-onset generalized erythrodermia,
hepatosplenomegaly, lymphadenopathy, hypoprotein- 1993).
The seventh patient (OS1) carried two missense muta-emia associated with hypereosinophilia, elevated serum
IgE, and presence of activated, anergic T cells. The tions in the Rag-2 gene, a C1324G transversion and a
T2055G transversion, causing a C41W and an M285Rimmunological features of four of them have been pre-
viously reported (Chilosi et al., 1996; Brugnoni et al., substitution, respectively. Both mutations are within the
Rag-2 active core (Sadofsky et al., 1994; Cuomo and1997), while the other three are described in Experimen-
tal Procedures. The 7 OS patients were analyzed for Oettinger, 1994) and involve amino acids conserved in
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Analysis of the TCRb Repertoire of OS Patients
All seven patients had variable yet detectable numbers
of T cells. To investigate the effect of the OS mutations
on V(D)J recombination, we determined the TCRb (TCRB)
repertoire. Our study included a global analysis of the
variable b (TCRBV) usage and the characterization of
TCRBV clonality of individual TCRBV segments, as de-
scribed elsewhere (Bettinardi et al., 1992; Sottini et al.,
1996; Imberti et al., 1997; see also Experimental Proce-
dures). In the OS patients studied (OS1 through OS4),
the recombination machinery was sufficiently functional
to recombine most TCRBV segments. However, the us-
age of individual TCRBV segments in OS samples dif-
fered from that of unrelated healthy infants of the same
ethnic origin with the fourOS patients (i.e., Italian) (Figure
2, last panel). In addition, TCRBV rearrangements in OS
patients showed restricted heterogeneity, as indicated
by heteroduplex analysis of several TCRBV subfamilies
prepared from patients OS1 to OS4 (Figure 2, first four
panels).
To confirm further the restricted heterogeneity of the
TCR repertoire in OS, we cloned and sequenced both
the TCRBV segments dominantly expressed in OS (such
as TCRBV6 in patient OS1, and TCRBV15 in patient
OS4), as well as the least represented OS TCRBV seg-
ments (such as TCRBV1 segments) (Table 2). This analy-
sis revealed a predominance of one or a few sequences
within each of the TCRBV transcripts analyzed in OS
Figure 1. Localization of OS Missense Mutations within the Rag-1 patients (Table 2). In contrast, sequencing of 2 different
and Rag-2 Proteins TCRBV transcripts from a control infant demonstrated
(A) Mutations R396H, R396C, and D429G map within the homeodo- that 60 out of 61, and 63 out of 64 clones, respectively,
main (HD) region of Rag-1 (Spanopoulou et al., 1996). Mutations were unique. Similar results were obtained with unfrac-
R561H and R561C map within the Rag-1 domain of interaction with
tionated lymphocytes from normal adults (QuiroÁ s Rol-Rag-2 (McMahan et al., 1997).
dan et al., 1995). In addition, N nucleotides were present(B) Rag-2 OS mutations C41W and M285R. The latter localizes within
in all sequenced junctions suggesting that these pa-the topoisomerase II homologous region of Rag-2 (Silver, 1994).
tients do not have deficiencies in terminal deoxynucleo-
tidyl transferase (TdT) activity (Table 2).
all the Rag-2 proteins from mammals, birds, and fish
Functional Analysis of the OS Rag-1(Sadofsky et al., 1994; Bernstein et al.,1996). M285 maps
and Rag-2 Mutationswithin a domain of Rag-2 demonstrating high homology
To determine whether the identified Rag mutations in theto the nonspecific DNA-binding domain of topoisomer-
OS patients can explain the partial immunodeficiency inase II (Figure 1B) (Silver et al., 1993; Berger et al., 1996).
OS, we tested the OS mutantRag proteins for their abilityMutations of patients OS1 through OS4, for whom
to mediate Rag-1/Rag-2 interaction, specific binding ofparent DNA was available, were traced back to their
the complex to the RSS, their cleavage activity and,parents. All parents were heterozygous for the Rag mu-
finally, their potential to mediate recombination of antant alleles and had normal counts of B and T cells.
extrachromosomal recombination substrate.The OS phenotype correlated with the presence of two
mutant Rag-1 or Rag-2 alleles in their offspring. The
possibility that the missense mutations represent rare Effect of OS Mutations on the
Rag-1/Rag-2 Interactionpolymorphisms was excluded by analysis of ethnically
matched populations. Rag-1 A2847G and Rag-2 C1324G Rag-1/Rag-2 interaction was assayed by coexpression
of the wild-type or mutant proteins in 293T cells asand T2055G point mutations were from Italian patients
and, as they modify a restriction enzyme site, they were previously described (Spanopoulou et al., 1995). Rag-1
OS mutations R396H, D429G, and R561H gst fusionanalyzed by RFLP analysis of amplified PCR products,
in 260 chromosomes from Italian control individuals. proteins (gst-Rag-1) were transiently expressed along
with influenza haemaglutinin (HA)-tagged wild-type Rag-2The remaining missense mutations were found in Italian
(G1794A, C1298T, G1299A), American (C1298T, C1793T, (Flu-Rag-2) in 293T cells. Lysed cellular extracts were
subjected to affinity precipitation using glutathioneG2322A), and in one case in a Yugoslavian (A1398G)
patient. We therefore sequenced 100 chromosomes beads, and the purified complexes were analyzed by
Western blot (Figure 3). Rag-1 homeodomain mutantsfrom American controls; inaddition, we performed SSCP
analysis on 100 chromosomes from Italian controls. In R396H and D429G maintained efficient interaction with
Rag-2, while interaction of Rag-1/R561H with Rag-2 wasno case were any of these mutations detected.
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Figure 2. Analysis of the TCRB Repertoire of
Total Lymphocytes from OS Patients
(Left) The 4 top graphs indicate the TCRBV
usage of peripheral lymphocytes prepared
from patients OS1±OS4, while the bottom one
represents the mean and standard deviation
obtained by analyzing lymphocytes prepared
from four unrelated healthy children.
(Right) Heteroduplex analysis of the indicated
TCRBV chains obtained by PCR performed
with BV family-specific primers on lympho-
cytes prepared from four OS patients (four
top pictures) and from a representative
healthy child (bottom). TCRBV8 amplified
products, prepared from monoclonal and
polyclonal cell preparations, were used as
controls and loaded into the first and second
lines of each gel.
reduced to about 40% of the wild-type levels (Figure DNA Binding Activity of the OS Mutants
The effect of OS mutations on the binding of Rag-1/3A). To test the efficiency of interaction of OS Rag-2
mutants C41W and M285R with Rag-1, gst-Rag-2 pro- Rag-2 to the RSS was tested by electrophoretic mobility
shift assays (EMSAs) (Hiom and Gellert, 1997) using puri-teins were coexpressed with HA-tagged Rag-1 wild-
type protein (Figure 3B). Both OS Rag-2 mutations fied recombinant proteins (Spanopoulou et al., 1996).
Binding of wild-type Rag-1/Rag-2 to the RSS producesshowed reduced interaction with Rag-1 despite the fact
that the two mutations are in different parts of the Rag-2 two complexes (Figure 4, lane 1) that both contain Rag-1
and Rag-2 (Santagata et al., 1998). The upper complexmolecule. In all cases, the expression of each individual
mutant protein was tested by Western blot analysis of results from homodimerization of Rag-1, in part through
its homeodomain region (V. Aidinis and E. S., unpub-the total cell extract, which revealed that all proteins
were expressed at equal levels (Figures 3Aand 3B, lower lished data), while the lower complex represents the
monomeric form of the Rag-1/Rag-2 heterodimer. Muta-panels).
Rag-1 and Rag-2 Mutations in Omenn Syndrome
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Table 2. Sequences of TCRB Transcript from Omenn Syndrome (OS) Patients
TCRBV Na TCRBDb Na TCRBJd Frequency
OS4 TCRBV1
CTGTGCCA . . . . . . . . . CC GGACAGGGGG GAGGG .....ACTGAAG (1S1) 9/14
CTGTGCCAGCAG . . . . . GTC GACAGGG AAAA .......ATACGC (2S3) 3/14
CTGTGCCAGCAGCGTAG GGAGG ATAGC .......GACCC (2S5) 2/14
TCRBV15
CTGTGCCACCAGTGATT . . CATACATCC GGGACAGGG .GCACAGATACGC (2S3) 13/13
OS1 TCRBV1
CTGTGCCAGCA . . . . . . GACAGGGG .......AATTCACCCC (1S6) 14/28
CTGTGCCAGCAGCGTAG GCG TC .....GAGACCC (2S5) 3/28
CTGTGCCAGCAGCGTAG GGGG ......CGAGC (2S7) 1/28
CTGTGCCAGCAGCGTAG GGACTAG ...CTACGAGC (2S7) 1/28
CTGTGCCAGCAGCGTAG A AGGGGGC C ..CCTACGAGC (2S7) 6/28
CTGTGCCAGCAGC . . . . CC GGGG AA CTCCTACGAGC (2S7) 1/28
CTGTGCCAGCAGC . . . . CCGG CAGGG CCTG ..CCTACGAGC (2S7) 1/28
CTGTGCCAGCAGC . . . . CCCGCCGTAAGc CTCCTACGAGC (2S7) 1/28
TCRBV6
CTGTGCCAGCA . . . . . . . CCCGATTGATC GGGGC CCCACAAGT ..CACAGATACGC (2S3) 1/10
CTGTGCCAGCAGCT . . . . GGACAGGGGG ...CTACGAGC (2S7) 8/10
CTGTGCCAGCAGCTTA . . ATTGG TAGCG AGGG ......CGAGC (2S7) 1/10
a A few of these nucleotides can be considered as P nucleotides.
b The underlined sequences pertain to D1, while the others are from D2.
c Two of these nucleotides could be derived from the D sequence.
d The specific J segments are indicated in parentheses.
tion R396H decreased the affinity of both complexes Recombination Activity of OS Mutants
on Extrachromosomal Substrates(Figure 4, lane 2). The second OS mutation in the Rag-1
To test the ability of OS mutants to mediate recombina-homeodomain (D429G) produced a different result. This
tion of an extrachromosomal substrate in vivo. Rag-1,mutation had little effect on thebinding of the lower Rag-
Rag-2, and the recombination substrates pJH200 (de-1/Rag-2 complex to the RSS but it severely decreased
letional) and pJH288 (inversional) (Lieber et al., 1988)formation of the upper complex (Figure 4, lane 3). Thus,
were cotransfected in NIH 3T3 cells. RecombinationD429G specifically disrupts Rag-1 homodimerization.
products were determined either by PCR analysis (Ro-The third Rag-1 mutation, R561H decreased binding of
man and Baltimore 1996; Spanopoulou et al., 1996) orboth the upper and the lower complexes (Figure 4, lane
by CamR.AmpR versus AmpR (Table 3). OS mutations4). The decreased DNA binding could bedue to the lower
within the Rag-1 homeodomain drastically reduced theefficiency of Rag-1 R561H/Rag-2 interaction (Figure 3A).
ability of the mutant proteins to mediate recombinationRag-2 mutants C41W and M285R gave no detectable
of the two substrates (Figure 6, lanes 3 and 4; Table 3).DNA binding activity (Figure 4, lanes 5 and 6), which
R396H produced only 5%±10% of the wild-type recom-could be partly accounted for by their low efficiency of
bination activity whereas D429G impaired recombina-interaction with Rag-1 (Figure 3).
tion on the pJH288 substrate and produced 20% of the
wild-type activity on the pJH200 substrate (Figure 6A,Effect of OS Mutations on the Rag-1/Rag-2
lanes 3 and 4; Table 3). The Rag-1 R561H OS mutationCleavage Activity
that decreases efficiency of Rag-1/Rag-2 interaction re-The cleavage activity of the Rag-1 and Rag-2 OS mu-
duced overall recombination efficiencyto approximately
tants was tested by incubation of purified recombinant
1/3 of that of the wild-type protein (Figure 6A lane 5;
Rag proteins with a 12RSS substrate labeled at the 59
Table 3).All three OS Rag-1 mutations exhibited a similar
end of the top strand. Conditions for the in vitro cleavage phenotype when analyzed either in the context of the
reactions were similar to the DNA binding conditions active core or as full-length proteins, for in vivo recombi-
described by Hiom and Gellert (1997) (see Experimental nation (data not shown).
Procedures and Santagata et al., 1998). The nicking ac- The two OS mutations in Rag-2 showed a differential
tivity of all Rag-1 and Rag-2 OS mutants was directly phenotype. C41W showed diminished recombination
proportional to their DNA binding activity (compare Fig- activity (Figure 6B, lane 8), in accordance with its DNA
ures 4 and 5), while hairpin formation followed a slower binding and cleavage activities (see Figures 4 and 5).
rate. Rag-1 R396H had cleavage activity at about 30% However, M285R was able to mediate recombination of
of that of the wild-type protein (Figure 5A, lanes 2 and the two recombination substrates at 15%±20% of the
6) (similar activity was observed for DNA binding, see wild-type levels (Figure 6B, lane 9). Overall, all OS mutant
Figure 3). Rag-1 D429G shows approximately 30% of proteins exhibited lower recombination efficiency in me-
the wild-type activity (Figure 5A, lanes 3 and 7), while diating inversion of the pJH288 substrate than deletion
R561H retains only 10% of the wild-type activity (Figure of the pJH200 substrate (Figure 6). An aliquot of the
5A, lanes 4 and 8). OS mutations C41W and M285R in cells used for the recombination assays was lysed and
Rag-2 showed no obvious cleavage in accordance with probed by Westernanalysis for expression of the various
recombinant Rag proteins (Figure 6, lower panel).their diminished DNA binding activity (Figure 5B).
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Figure 4. DNA Binding Profile of OS Mutant Rag-1 and Rag-2 Pro-
teins
Purified proteins were incubated with 32P-labeled oligonucleotide
containing the 12RSS heptamer-nonamer motifs; ternarycomplexes
were cross-linked with glutaraldehyde and resolved by EMSA asFigure 3. Effect of OS Mutations on the Rag-1/Rag-2 Interaction
previously described (Hiom and Gellert, 1997). Cleavage products
Wild-type or mutant proteins were transiently expressed in 293T
can be visualized at the bottom of the gel.
cells and interaction was evaluated by coprecipitation assays.
(A) Rag-1 OS mutants R396H, D429G and R561H were expressed
as gst fusion proteins in the context of the human Rag-1 protein
active core (aa 333±1043). Recombinant Rag-1 proteins were coex- by mutations in the Rag-1 and Rag-2 genes that confer
pressed with HA-tagged Rag-2 active core (aa 1±388).
partial activity and allow only a low degree of V(D)J(B) Rag-2 OS mutants C41W and M285R were expressed as gst
recombination to occur.fusion proteins in the context of full-length human Rag-2. Recombi-
nant proteins were coexpressed with HA-tagged Rag-1 active core.
The lower panels represent Western analysis of the total cell lysates Genotype of OS
to detect the levels of expression of each recombinant protein.
Five of the OS missense alleles affect either the 396 or
561 Rag-1 codons, but in four of the cases different
nucleotides are involved. This finding, together with theDiscussion
fact that the two patients with the same C1298T transi-
tion are of different ethnic origin (OS6 is English-Ameri-We present evidence that a defect in the Rag-1 and
Rag-2 genes is responsible for Omenn syndrome, a se- can, while OS3 is Italian), suggests that the mutated
codons could represent a hot spot for mutations. Anvere combined immunodeficiency with substantial num-
bers of activated, oligoclonal T cells. This finding is sur- alternative explanation, however, would be that only a
limited number of residues in the Rag genes can beprising because previously described Rag mutations led
to a complete absence of mature B and T cells, as altered in order to maintain the partial recombinase ac-
tivity necessary for the OS phenotype. Previous analy-manifested by the SCID phenotype in both humans and
mice (Mombaerts et al., 1992; Shinkai et al., 1992; ses of B2T2 SCID patients have shown that the complete
lack of mature B and T cells in those patients resultedSchwarz et al., 1996). Three factors demonstrate the link
between mutations in the Rag genes and the appear- from either truncations of the Rag genes or missense
mutations in the active core of the two proteins thatance of the OS phenotype. First, appearance of the
OS immunodeficiency correlates with mutations onboth eliminated Rag function (Schwarz et al., 1996). In con-
trast, the OS mutant Rag proteins retain part of theirRag-1 or Rag-2 chromosomal alleles. Second, analysis
of more than 400 chromosomes from healthy individuals, activity, which appears to account for the recombination
events present in the T cells of these patients. The issueethnically matched to the OS patients, showed that
these mutations do not represent polymorphisms in the then arises as to what level of Rag activity is required
for the establishment of a functional immune system.general population. Third, all Rag mutations detected in
OS patients drastically reduce V(D)J recombination as The fact that the parents that are heterozygotes for
Rag-1 deletions 1723±1735 and 368±369 representjudged by in vitro and in vivo assays. From the genetic
and biochemical data reported in this paper, it can be healthy individuals with normal counts of B and T cells,
suggests that expression of only one allele is sufficientconcluded that the defect in Omenn syndrome is caused
Rag-1 and Rag-2 Mutations in Omenn Syndrome
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Figure 5. Cleavage Activity of OS Mutant
Rag-1 and Rag-2 Proteins
Purified proteins were incubated with the
12RSS substrate labeled on the upper strand,
and cleavage products, nicked intermedi-
ates, and covalently sealed hairpins were re-
solved on a denaturing polyacrylamide gel.
for normal V(D)J recombination and immunocompe- structure of the protein. The other OS Rag-2 mutation,
M285R, maps within a region of Rag-2 that shows dis-tence. In addition, none of the OS missense mutations
have a dominant negative effect since the heterozygous tinct homology to the nonspecific DNA-binding domain
of topoisomerase II (Silver, 1994; Berger et al., 1996).parents have a normal immune system.
The function of this topo II homologous domain of Rag-2
remains to be defined.M285R follows the pattern of C41WOS Mutations that Affect Rag-1/Rag-2 Interaction
Three of the OS mutations, Rag-1 R561H, Rag-2 C41W, in that it interacts with Rag-1 with lower efficiency and
has almost undetectable DNA binding and cleavage ac-and Rag-2 M285R, have a significant effect on the Rag-
1/Rag-2 interaction. R561H is within a region of Rag-1 tivity in vitro. However, in vivo the protein retained about
20% of the wild-type activity. This enhanced in vivothat mediates interaction with Rag-2 (McMahan et al.,
1997) and decreases efficiency of interaction by z80%. activity might be conferred by conformational changes
through the interaction with other cellular proteins.Mutations that affect the Rag-1/Rag-2 association might
have a more dramatic effect during recombination in
lymphocytes than when assayed in the in vitro or fibro- OS Mutations within the Rag-1 Homeodomain
Three of the seven OS patients characterized in thisblast assays. In lymphocytes, endogenous Rag-1 and
Rag-2 are present in limiting amounts, and efficiency of study carried a missense mutation at position R396.
R396 is at the N terminal of the Rag-1 homeodomainRag-1/Rag-2 interaction is critical for V(D)J recombina-
tion to occur. In contrast, both the in vitro and fibroblast within the region of Rag-1 (GGRPR, aa 392±396) that
shows absolute homology to the DNA-binding domainassays are conducted in the presence of high levels
of Rag-1 and Rag-2 augmenting the efficiency of their of the Hin invertase (Difilippantonio et al., 1996; Spano-
poulou et al., 1996). We have previously shown that theinteraction. It is therefore possible that the effect of
Rag-1 R561 in lymphocytes is far more pronounced than equivalent positions in mouse Rag-1 are important for
binding of the protein to the nonamer motif (Spanopou-in the in vitro assays.
OS mutation C41W in Rag-2 provides a radical change lou et al., 1996). Mutation of R396 in the human gene
reduces binding of the protein to the RSS, while it has noby the substitution of a Cys residue with Trp. This muta-
tion shows diminished DNA binding and cleavage activ- effect on the Rag-1/Rag-2 interaction.Given the effect of
this mutation on the repertoire of the OS patients theity that might result from a global change of the tertiary
Table 3. In Vivo Recombination Activity of OS Mutants
PCR Relative Recomb. pJH288
Amino Acid
Mutation pJH288 pJH200 CamR.AmpR/AmpR Efficiency Relative Recomb.
Rag-1 WT 100% 100% 232/26,710 0.86% 100%
Rag-1 R396H 5% 10% 39/28,230 0.14% 16%
Rag-1 #396C NA NA NA Ð Ð
Rag-1 D429G 5% 20% 18/25,370 0.07% 8%
Rag-1 R561H 23% 34% 63/27,300 0.23% 27%
Rag-1 R561C NA NA NA Ð Ð
Rag-1 R737H 8% 16% 15/29,840 0.05% 6%
Rag-1 Y912C NA NA NA Ð Ð
Rag-2 C41W 4% 10% 12/19,740 0.06% 7%
Rag-2 M285R 15% 30% 46/25,680 0.18% 22%
Values represent the average of five independent experiments analyzed by PCR and two analyzed by bacterial transformation. Statistical
variation for recombination efficiency by bacterial transformation ranged from 0.01±0.03% depending on the sample.
NA; not analyzed.
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E80A, in the recognition helix III of the CRX homeodo-
main also leads to disease. CRX is a photoreceptor-
specific transcription factor that belongs to the Paired
class of homedomains. Mutation of Glu-80 to Ala leads
to cone-rod dystrophy in humans (Freund et al., 1997).
Phenotype of OS
A major question that remains to be answered is why
partial V(D)J recombination activity leads to the OS phe-
notype. OS immunodeficiency is characterized by an
overrepresentation of Th2-type cells (as judged by in-
creased secretion of IL-4, IL-5, and IL-10), elevated se-
rum IgE, and eosinophilia (SchandeneÂ et al., 1993;
Chilosi et al., 1996; Brugnoni et al., 1997). The genetic
defect in OS allows productive rearrangement of multi-
ple TCRBV segments, yet the TCR repertoire in periph-
eral blood T cells is mostly oligoclonal. Selective expan-
sion of TCR clones may be a consequence of either
intrathymic selection of specific rearrangements or pe-Figure 6. Effect of OS Mutations on V(D)J Recombination Activity
ripheral expansion in response to infections, or both. In(A) OS human Rag-1 mutants were expressed in the context of the
addition, it is possible that mutations in the nonameractive core protein. Human Rag-2 mutants were expressed as full
DNA-binding domain of Rag-1 could lead to preferentiallength form. OS mutant Rag-1 or Rag-2 were expressed from the
peBG cassette (Spanopoulou et al., 1996). Plasmids expressing the recombination of certain TCRBV segments. Skewing to-
recombinant proteins were cotransfected along with the recombina- ward Th2 might be the result rather than the cause of
tion substrates pJH200 or pJH288 (Lieber et al., 1988) in NIH 3T3 the OS phenotype. As observed in other cases, immune-
cells, and 48 hr later recombination products were isolated. Recom-
deficient individuals have, by definition, an increasedbination efficiency was detected by PCR analysis using primers that
antigen exposure and a defect in antigen clearance thatdetect the recombined sequences (Roman and Baltimore, 1996). To
results in persistent high antigen load. If, as in OS, thecontrol for transfection efficiency and production of the recombinant
proteins, an aliquot of the cell lysate was analyzed by Western geneticdefect ispermissive and allows the development
analysis for the expression of the recombinant proteins (bottom of limited clones of mature T cells, the antigen overload
panel) detected with an anti-gst antibody. favors prolonged T cell activation that has been associ-
ated with increased IL-4 secretion and polarization to-
ward a Th2 phenotype (Hsieh et al., 1993; Hosken et al.,
question becomes whether low-affinity binding of Rag-1 1995).
mutants to the nonamer motif might drive preferential The high IgE levels and eosinophilia observed in OS
recombination of certain nonamer elements and/or hep- patients can be a direct response to the selective expan-
tamer-only dependent rearrangement. The availability sion of Th2 clones. In several mouse models high levels
of an animal model for the Rag-1 R396 mutation would of IgE production have been associated with the expan-
provide a tool to analyze the repertoire generated by sion of the NK1.1, IL-4 producing, Th2 cells (Yoshimoto
such a mutation and the role of the Rag-1 homeodomain et al., 1995; Bendelac et al., 1996). In addition, elevated
in vivo. serum IgE has been associated with the absence of the
TCRab lineage inTCRa-deficient mice (Wenet al., 1994).
In all of the above cases, as in OS, there is an imbalanceMutation OS Rag-1/D429G Affects
in the T±B network of interactions due to the preferentialRag-1 Homodimerization
expansion of certain T cell subsets with consequentThe other OS mutation within the Rag-1 homeodomain,
altered secretion of particular cytokines and Ig isotypes.D429G, maps to the first residue of the putative homeo-
This imbalance must be characteristic of only somedomain helix III (Spanopoulou et al., 1996). The mutation
lymphoid abnormalities. Other immunodeficient organ-specifically eliminates formation of the upper Rag-1/
isms, such as the V(D)J recombination-deficient SCIDRag-2 complex, which is partly mediated by homodimer-
mouse that has low levels of T cells or genetically engi-ization of the homeodomain (V. Aidinis and E. S., unpub-
neered mice with low numbers of B cells (such as thelished data). Therefore, D429 contributes to Rag-1 ho-
l5-/- mice), do not manifest a Th2 phenotype or highmodimerization, which might be crucial for synaptic
levels of IgE. Definitive answers on the pathogenesis ofcomplex formation. Homodimerization of homeodomain
OS will come from the establishment of animal modelsregions has been documented for the Paired class of
for the different OS mutations.homeodomains. The crystal structure of the Paired ho-
meodomain has shown that dimer formation is mediated
by a set of amino acids in the interphase of two domains V(D)J Recombination Activity in Omenn Syndrome
The datapresent in this study show that the immunodefi-that includes an acidic amino acid, Glu-42, present at
the first position of recognition helix III (Wilson et al., ciency in OS arises from missense mutations in the Rag
proteins that confer partial V(D)J recombination activity.1995). Asp-429 of the Rag-1 homeodomain is present
at the equivalent position with Glu-42. In this context, All of the OS patients (7/7) analyzed in this study carried
mutations in the Rag genes that can account for theit is interesting to note that mutation of the first residue,
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in two segments (94±1852 and 1781±3262) and Rag-2 in one seg-ªleakinessº of the OS phenotype. However, it is possible
ment (1201±2922). Sequencing was performed directly on the PCRthat certain mutations in the ubiquitous components of
products purified from the gel with the Thermosequenase kit (Amer-the V(D)J recombination machinery could also lead to
sham, U. K.).Mutations were confirmed by analysis of several clones
an Omenn-like phenotype. For example, in light of the from PCR amplification products cloned in TA vector (Invitrogen)
findings that Ku70-/- mice have low levels of T cells and and sequenced by the dideoxynucleotide chain termination method
using the Sequenase kit (USB), as previously described (Macchi etdevelop T cell lymphomas (Gu et al., 1997), it is conceiv-
al., 1995). For the analysis of restriction enzyme sites eliminated orable that a partial Ku70 function could produce an OS
created by the mutations, thepertinent PCR products were digestedphenotype associated with T cell lymphomas (Mache et
with the appropriate enzyme according to the suggestions of theal., 1994). V(D)J recombination deficiencies that lead
manufacturer. Single-stranded chain polymorphism (SSCP) was
to low-to-normal numbers of T cells in the absence of performed on small PCR products amplified with pertinent primers
mature B cells are a recurring theme. When the differen- and run according to standard methods.
tiation defect in Rag-/- or SCID mice is rescued by genetic
manipulation such as p53 or poly(ADP-ribose) polymer- Analysis of TCRB Repertoire
ase (PARP) inactivation or by damaging agents, the T Total cytoplasmic RNA and cDNA were prepared from peripheral
blood lymphocytes as previously described (Bettinardi et al., 1992),cell, but not the B cell compartment, is restored (Danska
and the cDNA was subjected to enzymatic amplification using aet al., 1994; Guidos et al., 1995, 1996; Bogue and Roth,
TCRBC primer (bAI: 59 CCC ACT GTG CAC CTC CTT CC 39) and a1996; Livak et al., 1996; Nacht et al., 1996; Morrison et
TCRBV degenerated primer: Vbd: 59 ACG TGA ATT CT(GT) T(ACT)
al., 1997). The mechanisms underlying these differences (CT) TGG TA(CT) (AC)(AG)(AT) CA 39. This amplification generates
between B and T cell development remain to be defined. a product of about 360 bp, which contains one-half of the V region
The elucidation of the molecular basis of the defect in gene and extends through the VDJ junctions until the first 165 bp
of the C region. The 40 cycles of PCR were carried out by combiningOmenn syndrome will permit the investigation of these
1 ml of cDNA in 100 ml of reaction volume containing 2.5 U of Taqmechanisms as well as the clinical features of the disease.
polymerase, dNTP at the final concentration of 250 mM each and
150 pmol of the Vbd primer and 50 pmol of the bAI primer in a buffer
Experimental Procedures prepared with 67 mM Tris-HCl (pH 8.8), 16.6 mM (NH4)2SO4, 10 mM
b-mercaptoethanol, 2 mM MgCl2, and 100 mg/ml of BSA. The PCR
Patients conditions were as previously described (Imberti et al., 1997).
We studied seven patients with typical signs of OS. The immunologi- The specificity of the total amplified products was analyzed using
cal features of four patients have been previously reported. Patient a colorimetric method (Bettinardi et al., 1992) and biotinylated
OS1 corresponds to G. M. in Chilosi et al., 1996. Patients OS2, TCRBV-specific probes. The relative percentage of expression of
OS3, and OS4 correspond to R. C., C. A., and C.N., respectively, in each individual TCRBV segment was calculated by dividing the sin-
Brugnoni et al., 1997. Patient OS5, the female child of non consan- gle TCRBV signals by the sum of the signals for all TCRBV families
guineous parents, developed generalized erythrodermia in the neo- and multiplying by 100. Subsequently, the TCRBV of interest were
natal period and chronic diarrhea and failure to thrive at two months individually amplified by 35 cycles of PCR, using TCRBV-specific
of age. At that time, eosinophilia (2024 cells/mm3) and increased oligonucleotides and the bAI TCRBC primer, and subjected to het-
serum IgE (500 U/ml) were manifested. Lymphocyte subpopulations eroduplex analysis as previously described (Sottini et al., 1996).
(%) were as follows: CD3 5 11, CD19 , 1, CD16 5 57. Virtually all Samples were denaturated at 958C for 5 min and then kept at 508C,
CD31 cells coexpressed CD45R0, a marker for primed T cells, and a temperature that is permissive for the annealing between either
93% of them were also DR1. In vitro lymphocyte proliferative re- homologous (homoduplex) or heterologous DNA strands, which
sponses to phytohemagglutinin (PHA) and anti-CD3 monoclonal an- have the same TCRBV family but differ for the N and the TCRBJ
tibody were abolished. Patient OS6 had eosinophilia (1400/mm3), regions (heteroduplex). The annealed samples were run on a 12%
normal numbers of peripheral blood lymphocytes (2,750/mm3), the acrylamide gel, and the gels were stained with ethidium bromide
majority (88%) being CD161 NK cells, with severely reduced CD31 and photographed under UV light. Amplified TRCBV8 products from
cells (4%), and absence of B cells. Virtually all circulating T lympho- the T cell line J77 and from lymphocytes stimulated with an anti-
cytes coexpressed the DR activation antigen. In vitro lymphocyte TCRBV8 monoclonal antibody were used as monoclonal and poly-
proliferation to PHA was abolished. clonal controls, respectively (Sottini et al., 1996). Specific PCRprod-
Patient OS7 developed generalized erythrodermia associated ucts of interest were purified, cloned, and sequenced as described
with lymphoadenopathy at 3 weeks of age and, subsequently, pre- (Sottini et al., 1996). The sequences were compared with published
sented with diarrhea, failure to thrive, splenomegaly, pneumonia, data relative to TCRBV, TCRBD, TCRBJ, and TCRBC segments
anemia, thrombocytopenia, and eosinophilia (5,200 cells/mm3). She (Arden et al., 1995).
had elevated serum IgE (800 U/ml at 3 months of age and 45,000
U/ml at 5 months) and an increased lymphocyte count (5,000±
Constructs13,000/mm3), with 54% CD31 T cells, most of which (74%) coex-
PCR products containing the mutations found in OS patients werepressed the DR antigen, and 2% B cells. The in vitro proliferative
cloned in TA vector and sequenced. Subsequently, PCR productsresponse to PHA was markedly reduced. Patients OS5 andOS7 have
were cloned in pEBG according to the general strategy of substitut-died after unsuccessful bone marrow transplantation, and sepsis,
ing restriction fragments cut with pertinent enzymes to the wild-typerespectively. All other patients have been cured by bone marrow
genes cloned in this vector. For protein expression, aa 330±1044 oftransplantation. In all patients, the autologous origin of T lympho-
human Rag-1 (Rag-1 active core; Sadofsky et al., 1993; Silver et al.,cytes (to rule out maternal T cell engraftment) was demonstrated
1993) and aa 1±527 of human Rag-2 or the corresponding fragmentsby HLA typing and by molecular analysis with highly polymorphic
from the mutant proteins were subcloned into the mammalian ex-markers (D1S80, APOB).
pression vector pEBG, which provides the coding sequences for
the glutathione transferase gene (gst) (Spanopoulou et al., 1995).Strategy for Mutation Identification in the Rag-1
and Rag-2 Genes
Rag-1 and Rag-2 coding sequences were amplified from genomic Protein Expression and Purification
Gst-fusion recombinant forms of the human Rag-1 and Rag-2 pro-DNA. All the patient DNAs were obtained before bone marrow trans-
plantation. DNAs were obtained also from the parents of OS1, OS2, teins were overexpressed in 293T cells and purified as previously
described (Spanopoulou et al., 1996). Proteins were dialyzed inOS3, and OS4 patients. Primers were designed for the amplification
of the Rag genes based on the sequences reported in databases cleavage buffer and quantified by Coomassie blue staining following
SDS±PAGE.(Rag-1: a.n. M29474; Rag-2: a.n. M94633). Rag-1 gene was amplified
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In Vitro Cleavage Reactions Telethon, Italy (no. E.495 to A. V. and no. E.668 to L. D. N.) and
MURST (to L. D. N.). E. S. is a Cancer Research Institute ClinicalStandard reaction conditions were modifications of previously pub-
lished protocols (McBlane et al., 1995; Hiom and Gellert, 1997; San- Investigator and Howard Hughes Medical Institute Assistant Investi-
gator. This work is manuscript no. 19 of the Genoma 2000/ITBAtagata et al., 1998). Fifty nanograms of each protein, Rag-1 and
Rag-2, was incubated with 0.01±0.05 pmol of 32P end-labeled cleav- Project funded by CARIPLO.
age substrate in 25 mM MOPS-KOH (pH 7.0), 5 mM Tris-HCl (pH
8.0), 120 mM KOAc, 18 mM KCl, 10% dimethyl sulfoxide (DMSO), Received January 26, 1998; revised April 24, 1998.
2.2 mM DTT, 1mM Mg21, 0.5 mM nonspecific single-stranded DNA
with 50 ng of each protein and 0.01±0.05 pmol of 32P end-labeled
Referencesprobe in a final volume of 20 ml. Reactions were stopped by the
addition of 0.1% SDS and loading buffer. Samples were analyzed
Agrawal, A., and Schatz, D.G. (1997). RAG-1 and RAG-2 form aon 16% polyacrylamide denaturinggels. The upper strand sequence
stable postcleavage complex with DNA containing signal ends inof 12RSS cleavage substrate is: 59-ACGCGTCGACGTCTACACAG
V(D)J recombination. Cell 89, 43±53.TGATAAGCCCTGAACAAAAACCGGATCCGCG-39. Standard cleav-
age reactions employed 32P 59 end-labeled upper strand annealed Arden, B., Clark, S.P., Kabelitz, D., and Mak, T.W. (1995). Human
T-cell receptor variable gene segment families. Immunogenetics 42,to the unlabeled, complementary lower strand oligonucleotide.
455±500.
Electrophoretic Mobility Shift Assays Bendelac, A., Hunziker, R.D., and Lantz, O. (1996). Increased in-
Conditions were based on the previously published protocol (Hiom terleukin-4 and immunoglobulin E production in transgenic mice
and Gellert, 1997). Fifty nanograms of each protein was incubated overexpressing NK1 T cells. J. Exp. Med. 184, 1285±1293.
for 10 min at 308C with 0.01±0.05 pmol of 59 end-labeled probe in Berger, J.M., Gamblin, S.J., Harrison S.C., and Wang, J.C. (1996).
25 mM MOPS-HCl (pH 7.0), 1 mM MgCl2, 2.2 mM DTT, 1 mg of Structure and mechanism of DNA topoisomerase II. Nature 379,
bovine serum albumin (BSA), 0.5 mM of nonspecific primer (59-CCTC 225±232.
GAGCTCA TCAGCTTGCCTGTGGGCAGCTCGATCTCTTTGTCG-39),
Bernstein, R.M., Schluter, S.F., Bernstein, H., and Marchalonis, J.J.20% DMSO, and 120 mM potassium acetate. Cross-linking was
(1996). Primordial emergence of the recombination activating geneachieved by glutaraldehyde (final concentration 0.1% v/v) treatment
1 (RAG-1): sequence of the complete shark gene indicates homologyfor 10 min at 308C. Complexes were resolved on a 4% native poly-
to microbial integrases. Proc. Natl. Acad. Sci. USA 93, 9454±9459.acrylamide gel.
Bettinardi, A., Imberti, L., Sottini, A., Primi, D. (1992). Analysis of
amplifiedT cell receptor VBtranscripts by a non-isotopic immunoas-Rag-1/Rag-2 Protein Interaction Assays
say. J. Immunol. Methods 146, 71±80.Recombinant proteins, human gst-Rag-1 wild type or OS mutants
Bogue, M., and Roth, D.B. (1996). Mechanism of V(D)J recombina-and mouse influenza HA-tagged Rag-2 (Flu-Rag-2) or mouse HA-
tion. Curr. Opin. Immunol. 8, 175±180.tagged active core Rag-1 (Flu-Rag-1) and human gst-Rag-2, were
transiently transfected in 293T cells and after 48 hr their interaction Bogue, M.A., Wang, C., Zhu, C., and Roth, D.B. (1997). V(D)J recom-
potential was assessed by coprecipitation assays as previously de- bination in Ku86-deficient mice: distinct effects on coding, signal
scribed (Spanopoulou et al., 1995). and hybrid joint formation. Immunity 7, 37±47.
Brugnoni, D., Airo, P., Facchetti, F., Blanzuoli, L., Ugazio, A.G.,Catta-
In Vivo Recombination Assays neo, R., and Notarangelo, L.D. (1997). In vitro cell death of activated
Mutant proteins were tested for their recombination activity in NIH lymphocytes in Omenn's syndrome. Eur. J. Immunol. 27, 2765±2773.
3T3 cells. Human Rag-1 active core (aa 330±1043) was cotrans-
Cavazzana-Calvo, M., Le Deist, F., de Saint-Basile, G., Papado-
fected with mouse wild-type Rag-2 active core (aa 1±388) whereas
poulo, D., De Villartay, J.P., and Fisher, A. (1993). Increased radio-human full-length Rag-2 proteins were cotransfected with mouse
sensitivity of granulocyte macrophage colony-forming unitsand skinRag-1 active core (aa 330±1040). Recombinant constructs were ex-
fibroblasts in human autosomal recessive severe combined immu-pressed in NIH 3T3 cells along with the recombination substrates
nodeficiency. J. Clin. Invest. 91, 1214±1218.pJH288 or pJH200 (Lieber et al., 1988). Cells were transfected by
Chilosi, M., Facchetti, F., Notarangelo, L.D., Romagnani, S., Delcalcium phosphate precipitation and harvested 48 hr later. Recom-
Prete, G., Almerigogna, F., De Carli, M., and Pizzoli, G. (1996). CD30bined products were isolated as described previously (Oettinger et
cell expression and abnormal soluble CD30 serum accumulation inal., 1990) and analyzed for recombination frequency by PCR analysis
Omenn's syndrome: evidence for a T helper 2-mediated condition.(Roman and Baltimore, 1996). To ensure that the PCR assays follow
Eur. J. Immunol. 26, 329±334.a quantitative pattern, reactions were allowed to proceed for 25
Cortes, P., Weis-Garcia, F., Misulovin, Z., Nussenzweig, A., Lai, J.S.,cycles and controlled by limited dilutions (1/2, 1/10, 1/100, 1/1000)
Li, G., Nussenzweig, M.C., and Baltimore, D. (1996). In vitro V(D)Jof a recombined pJH288 plasmid DNA. Oligonucleotides detect the
recombination: signal joint formation. Proc. Natl. Acad. Sci. USA 93,recombined products by annealing to the joined heptamer signal
14008±14013.sequences (oligo-RA5) and to the CAT gene (oligo-RA14) (RA5:
59-CCAGTCTGTAGCACTGTGCAC-39 and RA14: 59-TCCAGCTGAA Cuomo, C.A., and Oettinger, M.A. (1994). Analysis of regions of
CGGTCTGGT-39). The reactions incorporated [32P]dCTP. Reaction Rag-2 important for V(D)J recombination. Nucleic Acids Res. 22,
products were analyzed on a 5% polyacrylamide gel and visualized 1810±1814.
by autoradiography. Relative recombination activity was estimated Danska, J.S., Pflumio, F., Williams, C.J., Huner, O., Dick, J.E., and
by phosphoimaging (Biorad). Alternatively, efficiency of recombina- Guidos, C.J. (1994). Rescue of T cell-specific V(D)J recombination
tion was estimated by transformation of the recovered plasmid DNA in scid mice by DNA damaging agents. Science 266, 450±455.
into electrocompetent MC1061 bacteria (Biorad) and analysis of the
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